Cytogen Announces Resignation of Director
Advertisement
Cytogen Corporation, a product-driven, oncology-focused biopharmaceutical company, today announced that H. Joseph Reiser, Ph.D. has tendered his resignation from the Company's Board of Directors, effective immediately. Dr. Reiser advised the Board of Directors that he was resigning his position in order to focus more on his current responsibilities and to further pursue certain personal interests. Dr. Reiser's resignation letter contained no disagreement with management concerning any matter relating to the Company's operations, policies or practices.
Dr. Reiser previously served as the Company's President, Chief Executive Officer and Director from August 1998 until December 2002, and thereafter remained on the Company's Board of Directors to provide continuity to the new management team.
James A. Grigsby, Chairman of the Company's Board of Directors, stated that "Joe Reiser has been instrumental in building Cytogen into a product- driven, oncology-focused organization over the past six years and the Board recognizes Joe's long-standing commitment to the Company and its stockholders. His willingness to serve on the Board during this transition period has been enormously helpful."
Other news from the department people
